PMM2-CDG is a disease that was first proposed in 1997 (11) and can present hyperinsulinemia, but most of the currently known literature on PMM2-CDG only mentions the hypoglycemic phenotype and insulin level at the time of hypoglycemia was not demonstrated detailed (12). This evidence concerns the gene INS and hyperinsulinism.